NORTHERN TRUST CORP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$5,639,780
-19.9%
1,034,822
-1.4%
0.00%0.0%
Q2 2023$7,039,173
-22.8%
1,049,057
+1.6%
0.00%
-50.0%
Q1 2023$9,118,794
+19.9%
1,032,706
+3.7%
0.00%0.0%
Q4 2022$7,604,924
-8.4%
995,409
-14.6%
0.00%0.0%
Q3 2022$8,301,000
+1.4%
1,165,834
+15.3%
0.00%0.0%
Q2 2022$8,183,000
+27.0%
1,011,562
+117.9%
0.00%
+100.0%
Q1 2022$6,443,000
-50.8%
464,258
-0.5%
0.00%
-50.0%
Q4 2021$13,087,000
-19.5%
466,407
-2.5%
0.00%
-33.3%
Q3 2021$16,254,000
-14.1%
478,220
+3.3%
0.00%0.0%
Q2 2021$18,921,000
+12.0%
463,066
+10.4%
0.00%0.0%
Q1 2021$16,888,000
-30.3%
419,470
+2.3%
0.00%
-40.0%
Q4 2020$24,240,000
+21.8%
409,936
+0.2%
0.01%
+25.0%
Q3 2020$19,902,000
+14.3%
409,229
+13.7%
0.00%0.0%
Q2 2020$17,406,000
+67.3%
359,766
-3.9%
0.00%
+33.3%
Q1 2020$10,404,000
+207.7%
374,551
+231.5%
0.00%
+200.0%
Q4 2019$3,381,000
-3.8%
112,993
-0.6%
0.00%0.0%
Q3 2019$3,513,000113,6940.00%
Q2 2019$000.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$23,152,51615.55%
BERYLSON CAPITAL PARTNERS, LLC 289,726$2,213,5076.45%
Matrix Capital Management Company, LP 11,572,590$88,414,5881.69%
Pier Capital, LLC 1,012,401$7,734,7441.27%
VIKING GLOBAL INVESTORS LP 29,993,708$229,151,9291.15%
Eagle Health Investments LP 607,860$4,644,0501.07%
Triatomic Management LP 130,805$999,3500.84%
Aristotle Atlantic Partners, LLC 1,880,567$14,367,5320.80%
Senator Investment Group LP 1,000,000$7,640,0000.69%
ARK Investment Management 9,201,245$70,297,5120.61%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders